Can an apple a day keep the doctor away?

Current Pharmaceutical Design

Volumn 10, Issue 27, 2004, Pages 3419-3429

  Raskin, Ilya ^a   Ripoll, Christophe ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Botanical drugs; Botanical therapeutics; Botanicals; Dietary supplements; Drug discovery; Functional foods; Human health; Natural products; Nutraceuticals; Phytochemicals

Indexed keywords

ACETYLSALICYLIC ACID; ALKALOID DERIVATIVE; ATROPINE; BRUCINE; CAMPTOTHECIN; CHINESE DRUG; CINCHONA BARK; COCAINE; CODEINE; COLCHICINE; DIGITALIS EXTRACT; EMETINE; GALANTAMINE; HERBACEOUS AGENT; HYOSCYAMINE; MORPHINE; MORPHINE DERIVATIVE; NICOTINE; PACLITAXEL; PEN T SAO; PHYSOSTIGMINE; PILOCARPINE; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; QUININE; RESERPINE; SALICYLIC ACID; SCOPOLAMINE; STRYCHNINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AGRICULTURE; ALZHEIMER DISEASE; BIOINFORMATICS; CANCER THERAPY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMBINATORIAL CHEMISTRY; COST BENEFIT ANALYSIS; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUSTRY; DRUG ISOLATION; DRUG MANUFACTURE; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; DRUG SYNTHESIS; FOOD; GENE EXPRESSION SYSTEM; GENETIC SCREENING; HEALTH CARE DELIVERY; HEART DISEASE; HIGH THROUGHPUT SCREENING; HISTORY OF MEDICINE; HUMAN; INDIVIDUALIZATION; LIFE EXPECTANCY; LONG TERM CARE; MALARIA; MATHEMATICAL COMPUTING; MEDICAL DECISION MAKING; MEDICAL TECHNOLOGY; PATIENT CARE; PHARMACY; PHYSICIAN; PHYTOCHEMISTRY; PLEIOTROPY; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY CONTROL; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; SPECIES CULTIVATION; STANDARDIZATION; TREATMENT PLANNING; VALIDATION PROCESS; WELLBEING;

ANIMALS; DRUG EVALUATION, PRECLINICAL; DRUG INTERACTIONS; FOOD; HUMANS; PHYTOTHERAPY; PLANTS; PRIMARY PREVENTION; REPRODUCIBILITY OF RESULTS;

EID: 4644229286     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612043383070     Document Type: Review

References (89)

1. Rouhi AM. Chem Eng News 2003; 81: 77-107.
2. Poulev A, O'Neal JM, Logendra S, Pouleva RB, Timeva V, Garvey AS, et al. Elicitation, a new window into plant chemodiversity and phytochemical drug discovery. J Med Chem 2003; 46: 2542-7.
3. Thain SC, Murtas G, Lynn JR, McGrath RB, Millar AJ. The circadian clock that controls gene expression in Arabidopsis is tissue specific. Plant Physiol 2002; 130: 102-10.
4. Rosenthal JP, Bhat A, Bridbord K, Gschwind LA, Keusch GT, Miller R, et al. Combining high risk science with ambitious social and economic goals. Pharmaceutical Biology 1999; 37: 6-21.
5. Class S. Pharma overview. Chem Eng News 2002; 80: 39-49.
6. Newman DJ, Cragg GM, Snader KM. Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 2003; 66: 1022-37.
7. Raskin I, Ribnicky DM, Komarnytsky S, Ilic N, Poulev A, Borisjuk N, et al. Plants and human health in the twenty-first century. Trends Biotechnol 2002; 20: 522-31.
8. Hasler CM. Functional foods: benefits, concerns and challenges-a position paper from the American Council on Science and Health. J Nutr 2002; 132: 3772-81.
9. Verpoorte R. Exploration of nature's chemo-diversity: the role of secondary metabolites as lead for drug development. Drug Dev Today 1998; 232-38.
10. Mendelson R, Balick MJ. The value of undiscovered pharmaceuticals in tropical forests. Econ Bot 1995; 49: 223-8.
11. Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci USA 2000; 97: 1433-7.
12. Iizuka N, Oka M, Yamamoto K, Tangoku A, Miyamoto K, Miyamoto T, et al. Identification of common or distinct genes related to antitumor activities of a medicinal herb and its major component by oligonucleotide microarray. Int J Cancer 2003; 107: 666-72.
13. Tao X, Cush JJ, Garret M, Lipsky PE. A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis. J Rheumat 2001; 28: 2160-7.
14. Tao X, Younger J, Fan FZ, Wang B, Lipsky PE. Benefit of an extract of Tripterygium wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. Arthritis & Rheumatism 2002; 46: 1735-43.
15. Su D, Song Y, Li R. Comparative clinical study of rheumatoid arthritis treated by triptolide and an ethyl acetate extract of Tripterygium wilfordii. Chin J Modern Dev Trad Med 1990; 10: 144-6.
16. Silva AMS, Weidenborner M, Cavaleiro JAS. Growth control of different Fusarium species by selected flavones and flavonoid mixtures. Mycol Res 1998; 102: 638-40.
17. Pietta P. Flavonoids in medicinal plants. In: Rice-Evans C, Packer L, editors. Flavonoids in Health and Disease. New York: Marcel Dekker, inc; 1998. p. 541.
18. DeFeudis FV. A brief history of EGb 761 and its therapeutic uses. Pharmacopsychiatry 2003; 36 Suppl 1: S2-7.
19. Pohar KS, Gong MC, Bahnson R, Miller EC, Clinton SK. Tomatoes, lycopene and prostate cancer: a clinician's guide for counseling those at risk for prostate cancer. World J of Urology 2003; 21: 9-14.
20. Rissanen T, Voutilainen S, Nyyssonen K, Salonen JT. Lycopene, atherosclerosis, and coronary heart disease. Exp Biol Med 2002; 227: 900-7.
21. Barber N, Barber J. Lycopene and prostate cancer. Prostate Cancer P D 2002; 5: 6-12.
22. Boileau TW, Liao Z, Kim S, Lemeshow S, Erdman JW, Jr., Clinton SK. Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets. J Natl Cancer Inst 2003; 95: 1578-86.
23. Eder M, Mehnert W. Bedeutung pflanzlicher Begleitstoffe in Extrackten. Pharmazie 1998; 53: 285-93.
24. Zanutto ME, Jordao Junior AA, Meirelles MS, Favaro RM, Vannucchi H. Effect of citric pectin on beta-carotene bioavailability in rats. Int J Vitam Nutr Res 2002; 72: 199-203.
25. Fuhr U. Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance. Drug Saf 1999; 18: 251-72.
26. Dresser GK, Bailey DG. The effects of fruit juices on drug disposition: a new model for drug interactions. Eur J Clin Invest 2003; 33 Suppl 2: 10-6.
27. Harris RZ, Jang GR, Tsunoda S. Dietary effects on drug metabolism and transport. Clin Pharmacokinet 2003; 42: 1071-88.
28. Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med 2002; 136: 42-53.
29. Markowitz JS, Donovan JL, DeVane CL, Taylor RM, Ruan Y, Wang JS, et al. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA 2003; 290: 1500-4.
30. Henderson L, Yue QY, Bergquist C, Gerden B, Arlett P. St John's wort (Hypericum perforatum): drug interactions and clinical outcomes. Br J Clin Pharmacol 2002; 54: 349-56.
31. Grody WW. Molecular genetic risk screening. Annu Rev Med 2003; 54: 473-90.
32. Burke W. Genetic testing. N Engl J Med 2002; 347: 1867-75.
33. King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003; 302: 643-6.
34. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998; 62: 676-89.
35. Roses AD. Genome-based pharmacogenetics and the pharmaceutical industry. Nat Rev Drug Discov 2002; 1: 541-9.
36. Negm RS, Verma M, Srivastava S. The promise of biomarkers in cancer screening and detection. Trends Mol Med 2002; 8: 288-93.
37. Surh Y. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3: 768-80.
38. Dong Z. Effects of food factors on signal transduction pathways. Biofactors 2000; 12: 17-28.
39. Lau BH. Suppression of LDL oxidation by garlic. J Nutr 2001; 131: 985S-8S.
40. Keli SO, Hertog MG, Feskens EJ, Kromhout D. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med 1996; 156: 637-42.
41. Wan Y, Vinson JA, Etherton TD, Proch J, Lazarus SA, Kris-Etherton PM. Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans. Am J Clin Nutr 2001; 74: 596-602.
42. McColl J. Health benefits of omega-3 fatty acids. NutraCos 2003; 2: 35-40.
43. Cornwell T, Cohick W, Raskin I. Dietary phytoestrogens and health. Phytochemistry 2004; 65: 995-1016.
44. Hosny M, Rosazza JP. New isoflavone and triterpene glycosides from soybeans. J Nat Prod 2002; 65: 805-13.
45. Bowles D. A multigene family of glycosyltransferases in a model plant, Arabidopsis thaliana. Biochem Soc Trans 2002; 30: 301-6.
46. Jones P, Vogt T. Glycosyltransferases in secondary plant metabolism: tranquilizers and stimulant controllers. Planta 2001; 213: 164-74.
47. Schuler MA, Werck-Reichhart D. Functional genomics of P450s. Annu Rev Plant Biol 2003; 54: 629-67.
48. Feher M, Schmidt JM. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J Chem Inf Comput Sci 2003; 43: 218-27.
49. Zurer P. When it comes to diversity, nature comes out ahead. Chem Eng News 1999; 77: 28.
50. Nicolaou KC, Pfefferkorn JA, Roecker AJ, Cao G-Q, Barluenga S, Mitchell HJ. Natural product-like combinatorial libraries based on privileged structures, I: General principles and solid-phase synthesis of benzopyrans. J Am Chem Soc 2000; 122: 9939-53.
51. Facchini PJ. Alkaloid biosynthesis in plants: Biochemistry, cell biology, molecular regulation, and metabolic engineering applications. Annu Rev Plant Physiol Plant Mol Biol 2001; 52: 29-66.
52. Dixon RA, Paiva NL. Stress-induced phenylpropanoid metabolism. Plant Cell 1995; 7: 1085-97.
53. Trapp S, Croteau R. Defensive resin biosynthesis in conifers. Annu Rev Plant Physiol Plant Mol Biol 2001; 52: 689-724.
54. Turlings TC, Tumlinson JH. Systemic release of chemical signals by herbivore-injured corn. Proc Natl Acad Sci USA 1992; 89: 8399-402.
55. Darvill AG, Albersheim P. Phytoalexins and their elicitors-a defense against microbial infection in plants. Annu Rev Plant Physiol Plant Mol Biol 1984; 35: 243-75.
56. Dixon PA. The phytoalexin response: elicitation, signaling, and control of host gene expression. Biol Rev 1986; 61: 239-291.
57. Ketchum RE, Gibson DM, Croteau RB, Shuler ML. The kinetics of taxoid accumulation in cell suspension cultures of Taxus following elicitation with methyl jasmonate. Biotechnol Bioeng 1999; 62: 97-105.
58. Wang C, Wu J, Mei X. Enhancement of Taxol production and excretion in Taxus chinensis cell culture by fungal elicitation and medium renewal. Appl Microbiol Biotechnol 2001; 55: 404-10.
59. Zabetakis I, Edwards R, O'Hagan D. Elicitation of tropane alkaloid biosynthesis in transformed root cultures of Datura stramonium. Phytochemistry 1999; 50: 53-56.
60. Eilert U, De Luca V, Constabel F, Kurz WG. Elicitor-mediated induction of tryptophan decarboxylase and strictosidine synthase activities in cell suspension cultures of Catharanthus roseus. Arch Biochem Biophys 1987; 254: 491-7.
61. Rijhwani SK, Shanks JV. Effect of elicitor dosage and exposure time on biosynthesis of indole alkaloids by Catharanthus roseus hairy root cultures. Biotechnol Prog 1998; 14: 442-9.
62. Malamy J, Carr J, Klessig DF, Raskin I. Salicylic acid-a likely endogenous signal in the resistance response of tobacco to tobacco mosaic virus infection. Science 1990; 250: 1002-4.
63. Kneer R, Poulev A, Olesinski A, Raskin I. Characterization of elicitor-induced biosynthesis and secretion of genistein from roots of Lupinus luteus L. J Exp Bot 1999; 339: 1553-9.
64. Metraux JP. Systemic acquired resistance and salicylic acid: Current state of knowledge. Eu J Plant Pathol 2001; 107: 13-18.
65. Farnsworth NR. Screening plants for new medicines. In: E.O. W, editor. Biodiversity; 1998; Washington D.C: National Academy Press; 1998. p. 83-97.
66. Cragg GM, Boyd MR, Cardellina JH, Newman DJ, Snader KM, McCloud TG. Ethnobotany and drug discovery: the experience of the US National Cancer Institute. Ciba Found Symp 1994; 185: 178-90; discussion 190-6.
67. van Drie JH. Pharmacophore discovery--lessons learned. Curr Pharm Des 2003; 9: 1649-64.
68. Ribnicky DM, Poulev A, Raskin I. The determination of salicylates in Gaultheria procumbens for use as a natural Aspirin alternative. J Nutra Functl Med Foods 2003; 4: 39-52.
69. Higuchi R, Fockler C, Dollinger G, Watson R. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology (NY) 1993; 11: 1026-30.
70. Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci U S A 1996; 93: 10614-19.
71. Debouck C, Metcalf B. The impact of genomics on drug discovery. Annu Rev Pharmacol Toxicol 2000; 40: 193-207.
72. Muller M, Kersten S. Nutrigenomics: goals and strategies. Nat Rev Genet 2003; 4: 315-22.
73. Jurado J, Prieto-Alamo MJ, Madrid-Risquez J, Pueyo C. Absolute gene expression patterns of thioredoxin and glutaredoxin redox systems in mouse. J Biol Chem 2003; 278: 45546-54.
74. Milligan G. High-content assays for ligand regulation of G-protein-coupled receptors. Drug Discov Today 2003; 8: 579-85.
75. Ko RJ. Adulterants in Asian patent medicines. N Engl J Med 1998; 339: 847.
76. Wadsworth T, Poonyagariyagorn H, Sullivan E, Koop D, Roselli CE. In vivo effect of PC-SPES on prostate growth and hepatic CYP3A expression in rats. J Pharmacol Exp Ther 2003; 306: 187-94.
77. Slifman NR, Obermeyer WR, Aloi BK, Musser SM, Correll WA, Jr., Cichowicz SM, et al. Contamination of botanical dietary supplements by Digitalis lanata. N Engl J Med 1998; 339: 806-11.
78. Ko R, Wilson RD, Loscutoff S. Pc-Spes. Urology 2003; 61: 1292.
79. Harkey MR, Henderson GL, Gershwin ME, Stern JS, Hackman RM. Variability in commercial ginseng products: an analysis of 25 preparations. Am J Clin Nutr 2001; 73: 1101-6.
80. Cui J, Garle M, Eneroth P, Bjorkhem I. What do commercial ginseng preparations contain? Lancet 1994; 344: 134.
81. Taylor JA, Weber W, Standish L, Quinn H, Goesling J, McGann M, et al. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. Jama 2003; 290: 2824-30.
82. van Dongen MC, van Rossum E, Kessels AG, Sielhorst HJ, Knipschild PG. The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial. J Am Geriatr Soc 2000; 48: 1183-94.
83. Mix JA, Crews WDJ. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings. Hum Psychopharmacol 2002; 17: 267-77.
84. Cheng Y, Chen M, Tong W. An approach to comparative analysis of chromatographic fingerprints for assuring the quality of botanical drugs. J Chem Inf Comput Sci 2003; 43: 1068-76.
85. Galili G, Galili S, Lewinsohn E, Tadmor Y. Genetic, Molecular, and Genomic Approaches to Improve the Value of Plant Foods and Feeds. Critical Reviews in Plant Sciences 2002; 21: 167-204.
86. Farnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo Z. Medicinal plants in therapy. Bulletin of the World Health Organization 1985; 63: 965-81.
87. Kurowska EM. Nitric oxide therapies in vascular diseases. Curr Pharm Design 2002: 8(3): 155-66.
88. Meisel H, FitzGerald RJ. Biofunctional peptides from milk proteins: mineral binding and cytomodulatory effects. Curr Pharm Design 2003; 9(16): 1289-95.
89. Mercenier A, Pavan S, Pot B. Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr Pharm Design 2003; 9(2): 175-91.